Review of modern phlebotrophic preparations based on flavonoids as perspective endothelioprotectors in the treatment of chronic diseases of the veins by A. V. Voronkov, O. Yu. Gamzeleva

Get full text

Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials by V. S. Kosorukov, G. R. Abuzarova, E. R. Zakharochkina, O. Yu. Gamzeleva, K. A. Yatsenko

Get full text

Selective opioid agonist Taphalgin® as a component of postoperative analgesia in various surgical areas: “NIKITA” observational multicenter study by A. E. Karelov, A. M. Ovezov, I. B. Zabolotskikh, V. E. Khoronenko, G. R.  Abuzarova, T. S. Musaeva, T. V. Klypa, G. V. Rodoman, M. I. Alexandrov, S.  A. Bozhkova, A. V. Boyarkov, A. L. Potapov, I.  V. Shaimardanov, D. V. Yemelyanov, S. A. Ilyin, E. V. Neduruyev, N.  P. Shevchenko, G. S. Solovyov, A. S. Sorokin, O. Yu. Gamzeleva, Yu. N. Kraevskaya

Get full text